Delivery Order 75N93019D00016-75N93023F00001
Award Date 9/5/23
Potential Completion Date 9/4/24
Potential Value $549K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Birmingham, AL 35294, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a Firm Fixed Price Delivery Order to the University of Alabama at Birmingham (UAB), doing business as U A B, for a "COMPREHENSIVE PANEL FOR VIRUSES" contract with a ceiling value of $1,053,577.42. The contract is under the broader In Vitro Antimicrobial Assessments 2011-2018 Indefinite Delivery Contract (IDC) and has a completion date of September 29, 2016. UAB is a non-profit, public research university...
- This delivery order was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to the University of Alabama at Birmingham to determine the antiviral inhibitory effect and cytotoxicity of experimental antiviral compounds against viruses listed in Groups 1, 2, and 3, as well as other rapidly emerging viruses that utilize the same assay methodology. The $586,919.16 contract was issued under the In Vitro Assessments of Antimicrobial Activity master...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of Alabama at Birmingham (UAB) to provide a "SUPPLEMENT TO COMPREHENSIVE PANEL FOR VIRUSES". The $26,500.00 Firm Fixed Price contract was awarded on March 24, 2015 as a Delivery Order under the "In Vitro Antimicrobial Assessments 2011-2018" Indefinite Delivery Contract (IDC). The contract has no set-aside designation. As a leading...
- This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to the University of Alabama at Birmingham (UAB) for a Comprehensive Viral Screening Panel to determine the antiviral inhibitory effect and cytotoxicity of experimental antiviral compounds against viruses. The contract is a Delivery Order under the "In Vitro Assessments of Antimicrobial Activity (IVAAA)"...
- This contract was awarded by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases to the University of Alabama at Birmingham (UAB), an internationally renowned research university and academic medical center. The contract, valued at $616,373.16, is a Firm Fixed Price Delivery Order under the "In Vitro Assessments of Antimicrobial Activity (IVAAA)" master IDIQ contract. The objective is to determine the...
- The University of Alabama at Birmingham (UAB) was awarded a $1,082 Firm Fixed Price delivery order contract by the National Institute of Allergy and Infectious Diseases (NIAID) to conduct in vitro assessments of antimicrobial activity. This contract is part of the "In Vitro Antimicrobial Assessments 2011-2018" Indefinite Delivery Contract (IDC) for NIAID. UAB, a public research university and academic medical center, has significant expertise in biomedical research, healthcare...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $499,760.00 firm fixed-price delivery order contract to the University of Alabama at Birmingham (UAB) for in vitro assessments of antimicrobial activity. This contract is under the parent "In Vitro Assessments of Antimicrobial Activity (IVAAA)" Indefinite Delivery Contract (IDC). UAB, a non-profit, state-controlled institution of higher...
- The National Institute of Allergy and Infectious Diseases awarded a delivery order valued at $560,418.16 to the University of Alabama at Birmingham (UAB) on December 16, 2024, for a Comprehensive Viral Screening Panel. This firm fixed-price delivery order is structured under the In Vitro Assessments of Antimicrobial Activity (IVAAA) master Indefinite Delivery/Indefinite Quantity (IDIQ) contract and does not utilize any set-aside designation. The work will be performed in Birmingham, Alabama,...
- This federal contract award, with an ID of HHSN272201100016I|HHSN27200013, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government. The contract is for "IN VITRO ASSESSMENT FOR ANTIMICROBIAL ACTIVITY" and was awarded to the University of Alabama at Birmingham (UAB), a public research university, on September 13, 2016. The contract has a ceiling value of $1,066,560.00 and runs through September 15, 2017. It is a...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to the University of Alabama at Birmingham (UAB) to provide in vitro assessments for antimicrobial activity. The contract, valued at $12,178, is a delivery order under the larger "In Vitro Antimicrobial Assessments 2011-2018" Indefinite Delivery Contract (IDC) vehicle. The award has a completion date of November 14, 2013,...